35 participants
Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-07
- Start Date:
- 2025-01-31
- Completion:
- 2025-12-31
Conditions
- Solid Tumors (Phase 1)
- Mesothelioma
- Colorectal Carcinoma
- Ovarian Cancer
- NSCLC (Advanced Non-small Cell Lung Cancer)
Interventions
- DRUG
No Results Yet